MDBR Interviews Harry Glorikian About the Growing Significance of In Vitro Diagnostics
Sharing his insight with MDBR, Glorikian discusses the recent release of his report, Commercializing Novel IVDs: A Comprehensive Manual for Success, and the role of in vitro diagnostics (IVD) today.
Harry Glorikian writes for Insight Pharma Reports, a division of Cambridge Healthtech Publishing.
Harry Glorikian, MBA
NEW BOOK
The Invisible Interface
Harry Glorikian’s new book explores how AI is quietly rewriting who controls your customer relationships, your workflow, and your competitive edge — before most executives realize it’s happening. Available June 30, 2026.